Skip to main content
Loading ResearchHub…
Table 2 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer | ResearchHub - ResearchHub